Abzena, a contract development and manufacturing organization (CDMO) specializing in complex biologics and bioconjugates, has announced an expansion of its quality control (QC) testing capabilities with a new microbiology lab in San Diego. The new facility is dedicated to enhancing analytical
October 30, 2024
In a significant advancement for International Process Plants (IPP), the Universal Glasteel Equipment (UGE) subsidiary has attained the American Society of Mechanical Engineers (ASME) 'R' Certificate for its facility in Eastover, South Carolina. This recent recognition permits IPP to
October 30, 2024
Rentschler Biopharma SE, a leading contract development and manufacturing organization (CDMO) specializing in biopharmaceuticals and advanced therapy medicinal products (ATMPs), has taken a monumental step towards bolstering its operational capabilities. The German-based company has announced its
October 24, 2024
Eurofins CDMO Alphora Inc., a contract development and manufacturing organization (CDMO), has recently taken a significant leap in its operational capabilities. The company has unveiled a new Active Pharmaceutical Ingredient (API) manufacturing facility in Mississauga, Canada. This expansion
October 24, 2024
The biopharma sector is facing a significant wave of layoffs in 2024, affecting thousands of employees across various companies. This trend is shaped by numerous internal and external factors, including corporate restructuring, market adaptations, strategic divestments, and cost-saving measures.
October 16, 2024
Catalent, a prominent contract development and manufacturing organization (CDMO), has announced the divestment of its Somerset, New Jersey, oral solids development and small-scale manufacturing facility to Ardena, a Belgian CDMO. This transaction marks Ardena's entry into the U.S. market and
October 15, 2024
